News Briefs
America’s National Cancer Institute (NCI) has acknowledged oleocanthal as a potential nutraceutical for breast cancer and awarded $399,999 to the company, Oleolive, for the development of the phenolic compound as a functional food to prevent breast cancer.
The funds will be used to research the preventative and therapeutic benefits of oleocanthal in triple negative breast cancer (TNBC) recurrence. Around 50,000 women in the United States are diagnosed with TNBC annually.
See Also:Health NewsA new, safe and effective recurrence inhibitor is urgently needed as the current outlook for TNBC patients is bleak due to high recurrence rates, poor overall survival rates and ineffective available treatments.
Oleocanthal experts Khalid El Sayed and Amal Kaddoumi, who are the company’s chief scientists and researchers at the University of Louisiana-Monroe, co-authored a 2017 study which revealed that oleocanthal was effective in preventing cancer and Alzheimer’s disease in mice and had the potential to become an effective dietary supplement for reducing the risk of developing both conditions.
El Sayed told Olive Oil Times the nutraceutical will be made available to patients once the team has established the desired potency and efficacy of the oleocanthal formulation for preventing TNBC recurrence. He said that further funding would be sought to prepare the formulation for clinical trials on humans.
“[I would] certainly recommend consumption of high-quality extra virgin olive oil daily for not only breast cancer survivors and patients but also for normal healthy people to maintain a condition of well-being based on the significant positive health outcomes documented by several clinical trials and epidemiological studies,” he said.
His recommendation was an average daily consumption of around 20 to 50 milliliters of olive oil per day, depending on an individual’s health and the quality of olive oil consumed. He advised new consumers of olive oil to start with smaller amounts (five to 10 milliliters) and gradually increase the daily dose over time.
More articles on: breast cancer, cancer prevention, oleocanthal
Jun. 13, 2023
Study Reveals Insights Into the Impact of Olive Oil Fats on Essential Cell Structures
The study found that worms consuming oleic acid lived longer than worms eating a standard diet. Whether these findings relate to humans requires more research.
Jun. 27, 2023
New Zealand Producer Uses Brix Levels to Determine Ideal Harvest Moment
Unlike with grapes or other fruit, Ross Vintiner harvests olives when the sugar level falls, indicating that oil is accumulating and polyphenol content remains high.
Oct. 24, 2023
Olive Grove Bacteria May Hold Key to Combating Xylella
Certain microorganisms provide biological advantages like a secondary immune system, researchers found.
Nov. 6, 2023
Polyphenol in EVOO May Shield Kidneys from Diabetes-Related Damage, Study Finds
Researchers investigated the use of dihydroxyphenylglycol, a polyphenol present in extra virgin olive oil, to treat kidney disease caused by type 1 diabetes.
Sep. 15, 2023
Using Effective Microbes to Boost Organic Olive Yields in New Zealand
Ross Vintiner, award-winning biodynamic olive farmer in New Zealand, believes that microbes are the future of farming.
Feb. 1, 2024
Olive Oil Metabolites Linked with Improved Cardiovascular Disease Outcomes
The research demonstrated a link between virgin olive oil metabolite profiles and reduced risk of cardiovascular disease, but not diabetes.
Mar. 10, 2024
Researchers Use Ultrasound to Detect Adulterated Olive Oil
They could detect extra virgin olive oil adulterated with as little as one percent sunflower or refined olive oil.
Jan. 15, 2024
Oleocanthal: Behind the Health Benefits of Olive Oil's Famous Phenol
Found solely in extra virgin olive oil, oleocanthal demonstrates potent anti-inflammatory properties and has been linked to beneficial impacts on cancer and dementia.